Enzon Pharmaceuticals, Inc. (ENZND)

Market Cap	38.70M +311.0%
Revenue (ttm)	n/a
Net Income	-5.53M
EPS	-7.46
Shares Out	6.45M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	786
Average Volume	800
Open	6.11
Previous Close	5.55
Day's Range	6.00 - 6.11
52-Week Range	1.50 - 12.99
Beta	0.08
RSI	51.09
Earnings Date	n/a

About Enzon Pharmaceuticals

Enzon Pharmaceuticals, Inc. does not have significant operations. Previously, it was engaged in the sale of its drug product, PegIntron. The company was formerly known as Enzon, Inc and changed its name to Enzon Pharmaceuticals, Inc. in December 2002. Enzon Pharmaceuticals, Inc. was incorporated in 1981 and is headquartered in Cranford, New Jersey.

• Industry: Biological Products, Except Diagnostic Substances
• Founded: 1981
• Employees: 1
• Stock Exchange: OTCMKTS
• Ticker Symbol: ENZND